Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
LESS than a pre-clinical with a Clinical Hold?
Tell me how that makes sense to anyone here? How a company with 100% owned CBR, CAR-T, CDX and Hu-PHEC with ~4m in the bank, Zero debt is currently worth less than half of what it was when it had a clinical hold, no expectation of trials in the immediate future, no cash and zero publicity or communication from the company?
It absolutely beggars belief that traders and shorters have managed to get the SP this low and its quite disgusting that LTHers who were supportive a month ago, having sold have decided to jump on the bandwagon. We all know Vlad has made mistakes, huge mistakes with regards to the funding choices over the years, but at the same time he has been financially responsible in his spending decisions and minimised what he NEEDS. Because of this there is no real "risk" he does not NEED money to keep going he needs money to accelerate other programs. This recent fiasco has however destroyed any possibility of a placing to pay for anything going forward which for me is a positive. Its almost like there are 2 completely different worlds here, the image of Hemo from this board where I have to assume everyone pictures people running around with fire extinguishers and rushing for the life boats before it sinks. Vs the realty that internally Hemo are working away, probably all oblivious to the share price, preparing for trials and getting on with day to day work with plenty in the bank.
Absolutely bonkers, the markets are a joke right now, Vlad would be well advised to take this private away from traders.
The abuse I get and have gotten for stating ANYTHING even remotely as a fact when its pure speculation is crazy, but you are allowed to state it has a lot further to fall, as a "Fact"? So what are the rules here? You can state anything you want as a "FACT" if its de-ramping but you cannot even suggest anything positive without getting jumped on?
Dhub, if you were a shareholder you would be calling out posts like yours as what it is a blatent attempted de-ramp, just because you have a lower target to buy back in does not mean your going to get it.
Roach was funding a lifestyle with a company that has hard assets, Vlad is... Whats the word? Ideologic? His goal is success and saving lives whilst maintaining as much control as possible over the company between himself and his wife. Everything is indeed possible, and yes if the mCap was 100m and he could raise 10m with % dilution allowing him to retain full ownership of everything then he of course would. Further more I am certain that was the plan post CH lift, the SP was supposed to re-rate significantly allowing Vlad to raise enough to fund everything and accelerate CBR and CDX as he stated prior.
Its not that I am saying your wrong, this is and was probably Vlads preference, its less paperwork, less headache, less oversight to raise a large amount at a much higher premium. But that opportunity did not happen, as much as that may have been Vlads intention it failed and at 1.7p it is now impossible, even if shareholders authorised him to raise more he would still require a prospectus and from the brokers I spoke to, right now no small pharma is raising anything near what would be required via a placing.
As much as people may portray this as a bad situation I am glad, I am sick to death of Vlad slipping in one more peterhouse special, handing the traders and shorters a gift on a silver platter when time and again its the LTHers who pay the price. If the door is firmly shut on vlad doing a placing to fund CBR? GOOD! He has balked at certain grants in the past because of the effort or restrictions imposed because he knew he could do a placing. He has kept 100% ownership of everything in lieu of partnerships, JV, Licencing because he knew he could get better down the line and could keep going with a placing. At this point NONE of us care. Raise money via JV, PIPE, Licencing, JV, BARDA, Grant, whatever and STOP going back for peterhouse specials.
The ONE good thing about all this shorting and low SP? Vlad has no other choice, placing here to fund CBR is just not possible. But he DOES have many many other options, it has been his choice to ignore them, and YES he does have other options, I was passed details of potential buyers for HEMO-CAR-T willing to discuss licencing it and when I forwarded to Hemo the response was its not for sale at this point. God knows how many other advances they have had and Vlad has said no time and time again. Of course he could licence or partner for something, and now he has no choice.
Guinness, the limit didn't need to be raised, he raised as much as was available last time and infact less than was first arranged as we know people pulled out. Basically 2 camps:
You believe he will limp along funding piecemeal via placing
Or you believe that at this price, with this market funding for CBR via placing is not available and Vlad will have to be willing to give away part of it to continue.
If the market significantly improves and sp is back 4,5,6p+ etc then maybe the situation will change. But we all know vlad needs SIGNIFICANT funds, 10m+ and that is not available via placing as we stand.
"where is the value to an investor tomorrow 8am" I guess for me its the point that we know that Vlad wants to progress CBR and CDX and he cannot do it on 3mil, we can all agree that. I think at this point most of us also appreciate that a placing, even if he did a prospectus to lift the 20% limit, would not give him enough to fund CBR or CDX.
So Vlad has a few choices, he either knuckles down and pushes CAR-T ASAP, get it into trials, get a few patients treated and sells it to fund the company.
OR he looks at alternatives to pursue CBR on its own legs, which means a JV, partnership, PIPE investments, grants etc.
The first would be the best profit wise for shareholders obviously in the longer run, few months waiting, delay CBR and raise enough in one licencing deal to fund the company for years.
HOWEVER
I dont believe he will wait. WHY? Not because he is not willing to wait, I am sure he would, but because everything I have seen from Vlad is that he is risk adverse, he would be gambling that HEMO-CAR-T works, that there is no subsequent hold and there is no delay in licencing. Its higher risk, delays CBR even further and if there are problems he would have to place just to keep the lights on.
The current mCap is pathetic, might aswell be free, it would be a rounding error on the balance sheets of any of the big pharma. Yet CAR-T is close to having clinical proof making it extremely valuable with a CEO who has stated he is willing to sell as soon as he has early clinical proof.
Honestly there are people out there that know this is massively undervalued and people are buying, but there was a huge placing, and sentiment is at all time lows and LTHers have sold. But the "compelling" argument to buy Hemo right now is huge, like literally I have been adding every opportunity and will continue to do so.
Sentiment can change in a heartbeat, a seller can turn to a buyer with the click of a mouse. We have seen selling on an epic scale and its pretty much ground to a halt and now the big buys are turning up. Hemo needs NOTHING to take off other than buys to outweigh sells. If there is any sort of update that includes grants, JV, PIPE, Licencing, BARDA etc it takes off without risk of the usual attack on placing. When trials start they will draw more visibility and hopefully new investments holding for results, again giving strength to the SP.
Will the SP Slide further? Maybe, I doubt it can go much further because we are seeing larger and larger buys, the SP tanked because of a glut of discount shares, not because CAR-T failed, not because CBR failed. The science here is good, the damage is done and when the storm is gone there will be plenty of traders and investors willing to pile in to take advantage of the fire sale prices.
Pwil, yes interviews before CH was lifted Vlad says how he was planning to ramp up CBR and CDX, clearly had big plans. The recent interview he is crystal clear, this did not go to plan, he is not able to progress CBR and CDX as planned and he is now actively pursuing alternative arrangements. Also yes I have spoken to investors and brokers etc since the placing and its clear that Vlad needs or atleast wants a level of funding that is not available via a placing. And I agree with you Guiness25 and have relayed as much to Hemogenyx, there is ZERO support for the level of placing that would be required to progress CBR at this SP. The company can issue another 5% to 2025 and at this price it means shelving CBR which is not an option.
I honestly dont know if he will go after grants, loan (see: https://www.fiercepharma.com/pharma/bluebird-bio-secures-175m-lifeline-hercules-capital-support-its-three-pricey-gene-therapies ), Licencing, partnership/JV however I have zero doubt he will want to ramp up CBR and that takes cash, raising another 1m in 3 months does NOTHING for the company, nada.
CBR/CDX/CAR-T are all quite huge, none of them have any encumberments which prevents Vlad from using them to raise cash. Vlad might want to keep 100% ownership? Well good luck to him, he is running out of alternatives, he blew it with the placings and he knows it.
Lol, I actually don't bother checking any more as I'm so confident you will find if 😊
Darwen, it's like special people who fly to Spain to complain the menu at McDonald's.stay at home and leaving Spain alone.
Guinness, not sure what you mean, its going to be a small trial, one at a time at Penn. Probably be found first on the clinical trials website before rns and my money is on HT finding it first.
46% drop on FA squared still aint very much, whats your audience here? Most of us know the SP is croop, we are not holding for what the SP is today we are holding for what it WILL be. Maybe if Hemo had not just raised millions the SP would be relevant, but its not, what matters is what happens next, where does money come from CBR, whom do they partner with, when do trials start. This obsession with SP is..... yea.
Indeed money will be made, and not by those who moan on here about a 2% drop!
When BUYS are big blocks and sells are small blocks the fat cats are loading up.
When SELLS are big blocks and buys are small blocks the fat cats are unloading to us "mere mortals"
We had the big block sells immediately after the placing, now its flipped and while some mere mortals seem content to sell at a loss, someone with deeper pockets than any of us is content to buy. Might be hard to top slice when this takes off, but you watch, when it does take off it will be NT to buy till the fat cats have finished accumulating.
Sscc I will wait while the science and logic tells me that is the right decision. If Hemo was a dog with nothing to show after these years? I would be long gone already. I would STILL be here today even if we had already had a re-rate, the only difference is I have not had an opportunity to top slice. Find the argument to be rather irrelevant to be fair, its like people who feel obliged to average down in a share that they dont believe in just because they are in so deep.
Been here what? 5-6 years? Irrelevant. Question is:
Today, Hemogenyx is CLINICAL, they have CAR-T lined up with Penn to go into clinical trials imminently, the next we hear will probably be a listing on the clinical trials website. They have cash in the bank, no debt and multiple candidates worth billions if they work. With a valuation of < 20m would I buy today?? Answer YES. But you make your own decisions, I am happy with mine.
Jonny, It SHOULD have already re-rated, going clinical bring Hemogenyx into the clinical sphere where it is without exception the most undervalued amongst its peers and that if you ONLY consider HEMO-CAR-T.
Dont misunderstand me, the focus IS on SP but its not on 5 or 10%, this daily obsession with what the SP has done in the past few hours is it up or down a few %? Thats an obsession on irrelevant intra day movements and does not interest me.
What I care about is what Hemogenyx is worth, and what it WILL be worth in the very near future. The sheer level of manipulation and shorting was shocking to myself and a huge eye opener to Vlad, its taken any sort of belief that he can just release a good RNS, raise the SP and fund via placing off the table. Going clinical was the biggest news the company has had in years and he ended up raising lower and using up his headroom, so for Vlad its time to do something different.
The number one preference for Vlad was minimal dilution large placing from a much higher SP, allowed him to retain 100% ownership of candidates inside Hemo vs licencing at a discount, less paper work and oversight which comes with grants.
But placing now for future work is off the table, Vlad had a kick in the balls and knows its not possible to raise what he wants via placing. I regret this was not already obvious to him and wish he had learned this lesson before doing a placing, but thats life
This company is currently valued at LESS than 20m? That is a farce, its a joke, it is wrong and most of us know that and thats why I am here. I care about the share price but I dont care about 1.7p or 2p or 3p or even 4p.
My mantra was this is undervalued when this was PRE-Clinical, we are now clinical, 3m in the bank and EVEN CHEAPER, so excuse me but undervalued does not even begin to do it justice.
Ofcourse this will re-rate, it has no choice, HEMO-CAR-T either works or it does not, either billions or nothing. CBR? Cannot progress without a huge cash injection, 3m was nothing, so he either licences/partners/goes after grants, any of which will cause a significant re-rate. Until that happens? spending hours posting about 2-3% up or down is an utter waste of time
Share price matters when you want to sell or they need to raise cash, neither apply right now :-)
If traders want to sell? If some LTHers want to sell? Let them, if you really cannot do anything but obsess about the SP day to day you really are here for the wrong reasons.... 2%is chicken feed. 10% is pittance. I dont care if it goes up 5% or down 5%.
The Company are funded into clinical trials, the potential price tag on HEMO-CAR-T could be up to a bn, certainly 100s of millions. so this daily obsession with a large section of the forum on ONLY posting about the SP and never mentioning the actual company, the science, what comes next? Clearly have no clue why they are here and what they are holding for, thats fine, I know why I am here, and right now the SP is just not even remotely a reflection of what it should and will be. I do see plenty of traders moaning and corresponding sells, and then I see large 2.5m buys just sweeping them all up and that gives me confidence at some point the traders will be long gone.
Positive spin? Traders keep selling and larger buy orders keep printing. If MMs making the SP red helps shake those shares loose? So be it.
Meh, out of the hands of traders. What's 44 multiplied by 3?
On the contrary, very few orchestrated trades, less botted orders on L2, most of the traders have decided to F off from LSE. But its a free world so believe what you want. Anyone who expects months of no news? Yeah, again, believe what you want! Although 2 weeks of silence would be good, I could transfer all remaining shares to isa's.
There is a good link at the top of that link Chris:
https://www.biospace.com/article/biotech-bankruptcies-skyrocket/
Validates what vlad said in his interview about hard to raise any money whatsoever and how important being careful to keep a rein on spending is.
To be fair and realistic here, I am pretty sure Vlad missed his opportunity to burn the shorters.. He had that chance, he could have said "Nope, SP too low not doing a discount placing we will do something else" but he went ahead after waiting just long enough for the SP to crash resulting in a 2p placing. So YES I love the idea of burning all the shorts but most of them are closed.
Hemogenyx made the move to SETS themselves, in theory if we were not seeing so much manipulation it would be a good thing. We lose some protections that are there to protect low volume stocks however the protections in question were just handing control over to the MMs who previously had Total control over the spread and could just refuse to buy or sell. Now? Everyone can play Market Maker and if we move the MMs cannot stop it.